Related Experiment Video
Updated: Aug 30, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Continuation of medically necessary aspirin and warfarin during cutaneous surgery
1Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minn 55905, USA.
Insights
For patients undergoing excisional cutaneous surgery, continuing medically necessary aspirin or warfarin is recommended. Discontinuing these anticoagulants poses risks of serious complications without reducing bleeding risk.
Area of Science:
- Dermatology
- Cardiology
- Surgery
Background:
- Excisional cutaneous surgery is frequently performed on patients requiring aspirin or warfarin.
- Perioperative management of anticoagulants during these procedures remains a topic of debate.
Purpose of the Study:
- To evaluate the risks and benefits of continuing or discontinuing aspirin and warfarin during excisional cutaneous surgery.
- To provide evidence-based recommendations for perioperative anticoagulant management.
Main Methods:
- Review of recent data on hemorrhagic and thromboembolic complications.
- Analysis of risks associated with perioperative discontinuation of aspirin and warfarin.
Main Results:
- Continuing aspirin and warfarin does not increase the risk of severe hemorrhagic complications.
- Brief discontinuation of these medications does not significantly lower the already minimal bleeding risk.
- Discontinuation of aspirin and warfarin is linked to life-threatening thromboembolic events.
Conclusions:
- Continuation of aspirin and warfarin is generally recommended for patients undergoing excisional cutaneous surgery.
- Individual patient risk factors and medical history are crucial for clinical decision-making.
- Clinical imperatives may warrant deviation from standard guidelines.
Abstract:
Excisional cutaneous surgery is performed commonly in patients who take medically necessary aspirin or warfarin. Although controversy has existed regarding the appropriate perioperative management of anticoagulant therapy during cutaneous surgery, recent data suggest that the risk of severe hemorrhagic complications is not increased if these medications are continued. Brief perioperative discontinuation does not lower this already minimal hemorrhagic risk. Furthermore, life-threatening thromboembolic complications have been related temporally to perioperative discontinuation of both aspirin and warfarin. In light of the absence of benefit and the presence of risks associated with discontinuation of warfarin and aspirin perioperatively during excisional cutaneous surgery, continuation of these medications is recommended in most situations. In all cases, the individual patient's medical history and risk factors should be taken into account when making this clinical decision, and deviation from the guidelines should be considered if clinical imperatives warrant.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...